QI
FOLD

QS Investors’s Amicus Therapeutics FOLD Stock Holding History

QS Investors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,634
Closed -$661K – 1207
2020
Q4 		$661K Sell
28,634
-466
-2% -$9.53K 0.01% 653
2020
Q3 		$411K Sell
29,100
-102,917
-78% -$1.5M 0.01% 793
2020
Q2 		$1.99M Hold
132,017
– – 0.03% 494
2020
Q1 		$1.22M Sell
132,017
-4,466
-3% -$42.5K 0.02% 606
2019
Q4 		$1.3M Hold
136,483
– – 0.01% 708
2019
Q3 		$1.09M Hold
136,483
– – 0.01% 759
2019
Q2 		$1.7M Sell
136,483
-2,551
-2% -$32.4K 0.02% 640
2019
Q1 		$1.89M Hold
139,034
– – 0.02% 625
2018
Q4 		$1.33M Hold
139,034
– – 0.02% 689
2018
Q3 		$1.68M Hold
139,034
– – 0.02% 663
2018
Q2 		$2.17M Sell
139,034
-1,937
-1% -$29.3K 0.02% 584
2018
Q1 		$2.12M Sell
140,971
-18,037
-11% -$274K 0.02% 561
2017
Q4 		$2.29M Buy
159,008
+7,483
+5% +$103K 0.02% 565
2017
Q3 		$2.29M Sell
151,525
-31,799
-17% -$421K 0.02% 568
2017
Q2 		$1.85M Hold
183,324
– – 0.02% 615
2017
Q1 		$1.31M Hold
183,324
– – 0.01% 719
2016
Q4 		$911K Hold
183,324
– – 0.01% 776
2016
Q3 		$1.36M Hold
183,324
– – 0.01% 721
2016
Q2 		$1M Hold
183,324
– – 0.01% 772
2016
Q1 		$1.55M Sell
183,324
-11,757
-6% -$83.3K 0.01% 687
2015
Q4 		$1.89M Sell
195,081
-2,527
-1% -$22.8K 0.02% 671
2015
Q3 		$2.77M Hold
197,608
– – 0.03% 533
2015
Q2 		$2.8M Hold
197,608
– – 0.03% 537
2015
Q1 		$2.15M Hold
197,608
– – 0.02% 581
2014
Q4 		$1.65M Buy
+197,608
New +$1.36M 0.02% 629

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QS Investors's FOLD Position: Q1 2021 in Review

QS Investors sold out of Amicus Therapeutics (FOLD) in Q1 2021, closing a stake of 28,634 shares — an estimated $661K sold.

QS Investors first reported a position in FOLD in Q4 2014 and held it in 25 quarters. The position peaked at $2.8M in Q2 2015. 259 funds tracked by Wall St. Rank hold FOLD as of Q1 2021.

  • QS Investors reported no remaining Amicus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • QS Investors sold 28,634 Amicus Therapeutics shares in Q1 2021, an estimated $661K.
  • QS Investors first reported a position in Amicus Therapeutics in Q4 2014 and held it in 25 quarters.
  • QS Investors's Amicus Therapeutics position peaked at $2.8M in Q2 2015.
  • 259 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2021.

Based on QS Investors's 13F filing for Q1 2021, filed 13 May 2021.